LNSR
LENSAR Inc
NASDAQ: LNSR · HEALTHCARE · MEDICAL DEVICES
$5.23
-2.97% today
Updated 2026-04-30
Market cap
$63.02M
P/E ratio
—
P/S ratio
1.08x
EPS (TTM)
$-2.87
Dividend yield
—
52W range
$5 – $14
Volume
0.1M
LENSAR Inc (LNSR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-58.70%
Operating margin
-116.00%
ROE
-1,069.00%
ROA
-22.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $24.39M | $-12.59M | 39.41% | -38.20% | -51.64% |
| 2019 | $30.53M | $-14.66M | 43.33% | -41.65% | -48.01% |
| 2020 | $26.38M | $-19.77M | 53.35% | -70.13% | -74.95% |
| 2021 | $34.46M | $-19.60M | 51.75% | -57.03% | -56.88% |
| 2022 | $35.36M | $-19.91M | 56.44% | -57.06% | -56.32% |
| 2023 | $42.16M | $-14.38M | 50.06% | -29.00% | -34.11% |
| 2024 | $53.49M | $-31.40M | 48.33% | -19.94% | -58.71% |
| 2025 | $58.44M | $-34.28M | 46.41% | -42.06% | -58.66% |